Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$4.19 USD
+0.20 (5.01%)
Updated May 31, 2024 04:00 PM ET
After-Market: $4.18 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.21 | -4.19% |
Earnings Summary
For their last quarter, Autolus Therapeutics (AUTL) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of -$0.10 per share. This reflects a negative earnings surprise of 140.00%. Look out for AUTL's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 19.23%.
Earnings History
Price & Consensus
Zacks News for AUTL
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
AUTL: What are Zacks experts saying now?
Zacks Private Portfolio Services